Theratechnologies Inc
THTX3.390USD
0.000
終値 11/06, 16:00（ET）15分遅れの株価
155.87M時価総額
損失額直近12ヶ月PER
詳細情報 Theratechnologies Inc 企業名
Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.
Theratechnologies Incの企業情報
企業コードTHTX
会社名Theratechnologies Inc
上場日Dec 21, 1993
最高経営責任者「CEO」Mr. Paul Levesque
従業員数94
証券種類Ordinary Share
決算期末Dec 21
本社所在地2015 Peel Street, 11th Floor
都市MONTREAL
証券取引所NASDAQ Capital Market Consolidated
国Canada
郵便番号H3A 1T8
電話番号15143367800
ウェブサイトhttps://www.theratech.com/
企業コードTHTX
上場日Dec 21, 1993
最高経営責任者「CEO」Mr. Paul Levesque
Theratechnologies Incの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Jocelyn Lafond
Mr. Jocelyn Lafond
General Counsel, Company Secretary
General Counsel, Company Secretary
--
-100.00%
Mr. Joseph P. Arena
Mr. Joseph P. Arena
Independent Director
Independent Director
--
--
Mr. John Leasure
Mr. John Leasure
Global Commercial Officer
Global Commercial Officer
--
-100.00%
Mr. Paul Levesque
Mr. Paul Levesque
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
-100.00%
Mr. Frank A. Holler
Mr. Frank A. Holler
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
-100.00%
Dr. Christian Marsolais, Ph.D.
Dr. Christian Marsolais, Ph.D.
Senior Vice President, Chief Medical Officer
Senior Vice President, Chief Medical Officer
--
-100.00%
Ms. Dale Maccandlish Weil
Ms. Dale Maccandlish Weil
Independent Director
Independent Director
--
-100.00%
Mr. Andre Dupras
Mr. Andre Dupras
Vice President of Human Resources
Vice President of Human Resources
--
--
Ms. Elina Tea
Ms. Elina Tea
Independent Director
Independent Director
--
--
Mr. Andrew Thomas Molson
Mr. Andrew Thomas Molson
Independent Director
Independent Director
--
-100.00%
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Jocelyn Lafond
Mr. Jocelyn Lafond
General Counsel, Company Secretary
General Counsel, Company Secretary
--
-100.00%
Mr. Joseph P. Arena
Mr. Joseph P. Arena
Independent Director
Independent Director
--
--
Mr. John Leasure
Mr. John Leasure
Global Commercial Officer
Global Commercial Officer
--
-100.00%
Mr. Paul Levesque
Mr. Paul Levesque
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
-100.00%
Mr. Frank A. Holler
Mr. Frank A. Holler
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
-100.00%
Dr. Christian Marsolais, Ph.D.
Dr. Christian Marsolais, Ph.D.
Senior Vice President, Chief Medical Officer
Senior Vice President, Chief Medical Officer
--
-100.00%
収益内訳
通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
事業別USD
会社名
収益
比率
EGRIFTA
11.13M
62.78%
Trogarzo
6.60M
37.22%
地域別USD
会社名
収益
比率
United States
17.73M
100.00%
事業別
地域別
事業別USD
会社名
収益
比率
EGRIFTA
11.13M
62.78%
Trogarzo
6.60M
37.22%
株主
更新時刻: Fri, Oct 17
更新時刻: Fri, Oct 17
株主統計
種類
株主統計
株主統計
比率
Future Pak LLC
100.00%
Worth Venture Partners, LLC
1.16%
Trium Capital LLP
0.69%
National Bank of Canada
0.48%
Stonepine Capital Management, LLC
0.41%
株主統計
株主統計
比率
Future Pak LLC
100.00%
Worth Venture Partners, LLC
1.16%
Trium Capital LLP
0.69%
National Bank of Canada
0.48%
Stonepine Capital Management, LLC
0.41%
種類
株主統計
比率
Corporation
100.00%
Investment Advisor/Hedge Fund
2.82%
Investment Advisor
1.66%
Bank and Trust
0.48%
Research Firm
0.32%
Hedge Fund
0.16%
機関投資家保有株
更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
75
2.49M
5.41%
-18.09M
2025Q2
91
22.32M
48.54%
-1.07M
2025Q1
91
22.45M
48.83%
-1.34M
2024Q4
86
23.57M
51.25%
-895.81K
2024Q3
83
24.25M
52.74%
-40.47K
2024Q2
85
24.07M
52.35%
-127.35K
2024Q1
90
23.97M
52.12%
-218.82K
2023Q4
90
24.01M
52.22%
+1.91M
2023Q3
92
7.44M
30.84%
-1.19M
2023Q2
93
7.55M
31.28%
-1.05M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Worth Venture Partners, LLC
533.40K
1.16%
-43.52K
-7.54%
Jun 30, 2025
National Bank of Canada
222.87K
0.48%
+25.80K
+13.09%
Jun 30, 2025
Stonepine Capital Management, LLC
189.05K
0.41%
+163.23K
+632.05%
Jun 30, 2025
SEB Investment Management AB
132.64K
0.29%
+132.64K
--
Jun 30, 2025
Dimensional Fund Advisors, L.P.
107.48K
0.23%
+77.64K
+260.12%
Jun 30, 2025
Harbour Investments, Inc
96.04K
0.21%
-67.00
-0.07%
Jun 30, 2025
Susquehanna International Group, LLP
80.67K
0.18%
+80.67K
--
Jun 30, 2025
Stifel, Nicolaus & Company, Incorporated
79.60K
0.17%
-500.00
-0.62%
Jun 30, 2025
詳細を見る
関連ETF
更新時刻: 18 hours ago
更新時刻: 18 hours ago
銘柄名
比率
DFA Dimensional International Core Equity 2 ETF
0%
DFA Dimensional International Core Equity 2 ETF
比率0%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
Jul 20, 2023
Merger
4→1
Jul 20, 2023
Merger
4→1
Jul 20, 2023
Merger
4→1
Jul 20, 2023
Merger
4→1
日付
種類
比率
Jul 20, 2023
Merger
4→1
Jul 20, 2023
Merger
4→1
Jul 20, 2023
Merger
4→1
Jul 20, 2023
Merger
4→1
